Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy.


The pathogenesis of fibrosis in chronic cyclosporine (CsA) nephropathy remains unknown. Since TGF-beta 1 plays a key role in the fibrogenesis of a number of renal diseases, we studied a salt-depleted rat model of chronic CsA nephropathy which shows similarity to the structural and functional lesions described in patients. Pair fed rats were treated with either CsA (15 mg/kg/day s.c.) or an equivalent dose of olive oil and sacrificed at 7 and 28 days. Characteristic histologic changes of proximal tubular injury, tubulointerstitial fibrosis and arteriolopathy developed in CsA-treated rats at day 28. They were accompanied by physiologic changes of increased serum creatinine, decreased creatinine clearance, increased enzymuria and decreased concentrating ability. CsA-treated rats showed a progressive increase in mRNA expression of TGF-beta 1 and matrix proteins at days 7 and 28. Most of the changes were in the tubulointerstitial and vascular compartments by immunofluorescence with a predominant involvement of the medulla as compared to cortex. The mRNA expression of plasminogen activator inhibitor, a protease inhibitor stimulated by TGF-beta 1, followed TGF-beta 1 and matrix proteins, suggesting that the fibrosis of chronic CsA nephropathy likely involves the dual action of TGF-beta on matrix deposition and degradation.


Citations per Year

1,131 Citations

Semantic Scholar estimates that this publication has 1,131 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Shihab1996RoleOT, title={Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy.}, author={Fuad S. Shihab and Takeshi F Andoh and April Michelle Tanner and Nancy A. Noble and Wayne A. Border and Nora Franceschini and William R. Bennett}, journal={Kidney international}, year={1996}, volume={49 4}, pages={1141-51} }